Ureteral Cancer

3 registered clinical trials studyying Ureteral Cancer — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Neoadjuvant Tislelizumab + Nab-Paclitaxel Followed by Distal Ureterectomy for Ureteral Cancer NCT07125547	Tianjin Medical University Second Hospital	Phase 2
Completed	A Study to Evaluate Enfortumab Vedotin Versus (vs) Chemotherapy in Subjects With Previously Treated Locally Ad NCT03474107	Astellas Pharma Global Development, Inc.	Phase 3
Completed	Postoperative Telerounding: A Multi-Center Prospective Randomized Assessment of Patient Outcomes and Satisfact NCT00263107	University of California, Davis	—